mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.

Zeng Y, Xu J, Wang J, Xue L, Liu J, Geisler HC, Ma X, Melamed JR, Shi Q, Padilla MS, Luo Z, Zhu J, Thatte AS, Figueroa-Espada CG, Ang MJY, Murray AM, Yamagata HM, Kim D, Metzloff AE, Weissman D, Mitchell MJ

Open source

DOI
10.1073/pnas.2525718123
Published
2026 Jul 14
Container
Proceedings of the National Academy of Sciences of the United States of America
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1073/pnas.2525718123,
  title = {mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.},
  author = {Zeng Y and Xu J and Wang J and Xue L and Liu J and Geisler HC and Ma X and Melamed JR and Shi Q and Padilla MS and Luo Z and Zhu J and Thatte AS and Figueroa-Espada CG and Ang MJY and Murray AM and Yamagata HM and Kim D and Metzloff AE and Weissman D and Mitchell MJ},
  year = {2026},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  doi = {10.1073/pnas.2525718123},
  url = {https://doi.org/10.1073/pnas.2525718123}
}

RIS

TY  - JOUR
TI  - mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.
AU  - Zeng Y
AU  - Xu J
AU  - Wang J
AU  - Xue L
AU  - Liu J
AU  - Geisler HC
AU  - Ma X
AU  - Melamed JR
AU  - Shi Q
AU  - Padilla MS
AU  - Luo Z
AU  - Zhu J
AU  - Thatte AS
AU  - Figueroa-Espada CG
AU  - Ang MJY
AU  - Murray AM
AU  - Yamagata HM
AU  - Kim D
AU  - Metzloff AE
AU  - Weissman D
AU  - Mitchell MJ
PY  - 2026
JO  - Proceedings of the National Academy of Sciences of the United States of America
DO  - 10.1073/pnas.2525718123
UR  - https://doi.org/10.1073/pnas.2525718123
ER  - 

APA

Y, Z., J, X., J, W., L, X., J, L., HC, G., X, M., JR, M., Q, S., MS, P., Z, L., J, Z., AS, T., CG, F., MJY, A., AM, M., HM, Y., D, K., AE, M., D, W., & MJ, M. (2026). mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity.. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2525718123

Source records